Home/Filings/4/0001209191-13-005382
4//SEC Filing

Murphy A Brett 4

Accession 0001209191-13-005382

CIK 0001237831other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 5:04 PM ET

Size

16.7 KB

Accession

0001209191-13-005382

Insider Transaction Report

Form 4
Period: 2013-01-30
Murphy A Brett
Executive VP, US Sales
Transactions
  • Sale

    Class A Common Stock

    2013-01-30$12.87/sh31,103$400,296121,217 total
Holdings
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $4.88Exp: 2019-08-06Class A Common Stock (9,230 underlying)
    9,230
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $11.87Exp: 2020-06-16Class A Common Stock (9,230 underlying)
    9,230
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $13.04Exp: 2023-01-24Class A Common Stock (25,000 underlying)
    25,000
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $10.66Exp: 2021-10-27Class A Common Stock (12,307 underlying)
    12,307
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $15.34Exp: 2022-08-29Class A Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $2.93Exp: 2016-11-01Class A Common Stock (107,692 underlying)
    107,692
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $11.28Exp: 2021-04-20Class A Common Stock (15,384 underlying)
    15,384
Footnotes (9)
  • [F1]This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on November 28, 2012, which is intended to comply with Rule 10b5-1 and was established in order to raise funds necessary to satisfy a tax obligation resulting from the exercise of a stock option in 2012.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.50 to $13.12, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  • [F3]These options were granted on November 1, 2006, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on November 1, 2007, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F4]These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F5]These options were granted on June 16, 2010, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F6]These options were granted on April 20, 2011, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on February 8, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F7]These options were granted on October 27, 2011, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F8]These options were granted on August 29, 2012, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F9]These options were granted on January 24, 2013, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Issuer

GLOBUS MEDICAL INC

CIK 0001237831

Entity typeother

Related Parties

1
  • filerCIK 0001555034

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:04 PM ET
Size
16.7 KB